Recurrent Grade 1 Follicular Lymphoma

Showing 26 - 50 of 93

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Stanford (biological, drug, radiation)

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +6 more
  • Ipilimumab
  • +2 more
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 17, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +99 more
  • fludarabine phosphate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 30, 2019

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 29, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +77 more
  • fludarabine phosphate
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 16, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +44 more
  • fludarabine phosphate
  • +9 more
  • Duarte, California
  • +6 more
Sep 6, 2019

Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial

Completed
  • Hematopoietic/Lymphoid Cancer
  • +22 more
  • CART-19
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jun 21, 2019

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1

Completed
  • Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +8 more
  • Scottsdale, Arizona
  • +1 more
Apr 4, 2019

Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • +33 more
  • therapeutic allogeneic lymphocytes
  • Stanford, California
    Stanford University
Mar 16, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +110 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 6, 2019

Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in

Completed
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • +7 more
  • Sacramento, California
    University of California Davis
Jan 2, 2019

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (rituximab, yttrium Y 90

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +8 more
  • rituximab
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 9, 2018

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +117 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Jun 28, 2018

B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma Trial in

Terminated
  • B-cell Adult Acute Lymphoblastic Leukemia
  • +26 more
  • 6,8-bis(benzylthio)octanoic acid
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma Trial in Atlanta, Columbus (drug, biological, other)

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +10 more
  • Atlanta, Georgia
  • +1 more
May 3, 2018

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1

Completed
  • Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +6 more
  • Duarte, California
  • +4 more
Feb 5, 2018

Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3

Completed
  • Contiguous Stage II Grade 1 Follicular Lymphoma
  • +32 more
  • pegfilgrastim
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 8, 2017

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +41 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 22, 2017

Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Seattle (drug, radiation, procedure)

Completed
  • Anaplastic Large Cell Lymphoma
  • +16 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jul 21, 2017

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +30 more
  • gemcitabine hydrochloride
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 28, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +82 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 26, 2017

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +36 more
  • Seattle, Washington
    Puget Sound Oncology Consortium
Apr 17, 2017

Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Marginal

Completed
  • Contiguous Stage II Grade 1 Follicular Lymphoma
  • +22 more
  • pharmacological study
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 14, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 17, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +96 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 10, 2017

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Terminated
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +33 more
  • Ipilimumab
  • Radiation therapy
  • Stanford, California
    Stanford University
Jan 12, 2017